SPDR S&P Pharmaceuticals ETF
XPH
XPH
68 hedge funds and large institutions have $128M invested in SPDR S&P Pharmaceuticals ETF in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 23 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
50% less call options, than puts
Call options by funds: $569K | Put options by funds: $1.14M
Holders
68
Holding in Top 10
–
Calls
$569K
Puts
$1.14M
Top Buyers
| 1 | +$19.4M | |
| 2 | +$11M | |
| 3 | +$2.58M | |
| 4 |
Rockefeller Capital Management
New York
|
+$2.51M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.89M |
Top Sellers
| 1 | -$5.01M | |
| 2 | -$4.45M | |
| 3 | -$1.74M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.04M |
| 5 |
LPL Financial
San Diego,
California
|
-$797K |
